New study to track brain health after CAR-T cancer treatment
NCT ID NCT07463781
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study follows 100 adults with certain types of lymphoma who are receiving CAR-T cell therapy. Researchers will test memory, attention, and other thinking skills before treatment and at 6, 12, and 24 months after. The goal is to learn how CAR-T therapy affects brain function over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CAR-T cell therapy
- What this could lead to
- If successful, this could help doctors better understand and manage memory and thinking problems that may occur after CAR-T therapy.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE-LARGE B-CELL LYMPHOMA (DLBCL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica di Ematologia, AOU Ospedali Riuniti
Ancona, Italy
-
Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello
Palermo, Italy
-
Ematologia - Grande Ospedale Metropolitano Bianchi Melacrino Morelli
Reggio Calabria, Italy
-
Ematologia - Università Cattolica S. Cuore
Roma, Italy
-
SC Ematologia - Ospedale "S.G. Moscati"
Taranto, Italy
-
SCDU Ematologia - AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Alessandria, Italy
-
SOC Clinica Ematologica - Azienda Sanitaria Universitaria Friuli Centrale (ASU FC)
Udine, Italy
-
USD-TMO Adulti - ASST Spedali Civili di Brescia
Brescia, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo keep aggressive lymphoma at bay?
- Can a simple blood test spot lymphoma earlier?
- Can a 'Universal' cancer target outsmart resistant blood cancers?
- What happens years after CAR-T therapy? a study aims to find out
- Can a single shot build a cancer army inside the body?
- Can a smart immune cell with a kill switch beat tough lymphomas?